Ad
related to: why ethosuximide used for absence seizure- Sign Up
Receive educational patient
support, tools, and resources.
- Find a Doctor
Be sure to locate a
doctor in your area.
- FAQs
Get your answers to the most
frequently asked questions.
- Treatment Options
Learn about partial-onset seizures
and an approach to treatment.
- Sign Up
Search results
Results from the WOW.Com Content Network
Ethosuximide, sold under the brand name Zarontin among others, is a medication used to treat absence seizures. [4] It may be used by itself or with other antiseizure medications such as valproic acid. [4] Ethosuximide is taken by mouth. [4] Ethosuximide is usually well tolerated. [5]
Although ethosuximide is effective in treating only absence seizures, valproic acid is effective in treating multiple seizure types including tonic-clonic seizure and partial seizure, suggesting it is a better choice if a patient is exhibiting multiple types of seizures. [25]
The pathophysiology of absence seizures has been linked to oscillatory thalamic-cortical potentials, calcium currents, and the interaction of GABAergic neurons. It seems clear that the pathophysiology of absence seizures differs from other epilepsies which may, in part, explain the unique efficacy of ethosuximide in this syndrome.
Therefore, almost all new epilepsy drugs are initially approved only as adjunctive (add-on) therapies. Patients whose epilepsy is uncontrolled by their medication (i.e., it is refractory to treatment) are selected to see if supplementing the medication with the new drug leads to an improvement in seizure control.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
So I understand the hesitation of the dog in this video, who wants to walk through the door the way he’s used to it opening. It’s still super funny, though. View the original article to see ...
A migraine attack can be a debilitating condition. But a headache is just one part. There are other subtle warning symptoms to watch out for, neurologists say.
The first-line treatments for childhood absence epilepsy, valproate and ethosuximide, are both blockers of T-type calcium channels; the second-line treatment, lamotrigine, although not a T-type calcium channel blocker, does inhibit high-voltage activated calcium channels. [9]
Ad
related to: why ethosuximide used for absence seizure